SGK
Steigerwald Gordon & Koch’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $609K | Sell |
3,283
-78
| -2% | -$14.5K | 0.06% | 75 |
|
|
2025
Q1 | $704K | Buy |
3,361
+123
| +4% | +$25.8K | 0.08% | 71 |
|
|
2024
Q4 | $575K | Sell |
3,238
-107
| -3% | -$19K | 0.07% | 81 |
|
|
2024
Q3 | $661K | Buy |
3,345
+101
| +3% | +$19.9K | 0.07% | 77 |
|
|
2024
Q2 | $556K | Buy |
3,244
+150
| +5% | +$25.7K | 0.07% | 79 |
|
|
2024
Q1 | $563K | Buy |
3,094
+163
| +6% | +$29.7K | 0.07% | 78 |
|
|
2023
Q4 | $454K | Sell |
2,931
-123
| -4% | -$19.1K | 0.06% | 83 |
|
|
2023
Q3 | $455K | Buy |
3,054
+757
| +33% | +$113K | 0.07% | 79 |
|
|
2023
Q2 | $310K | Buy |
2,297
+63
| +3% | +$8.49K | 0.05% | 89 |
|
|
2023
Q1 | $356K | Sell |
2,234
-4
| -0.2% | -$637 | 0.05% | 84 |
|
|
2022
Q4 | $362K | Buy |
2,238
+167
| +8% | +$27K | 0.06% | 85 |
|
|
2022
Q3 | $278K | Buy |
2,071
+37
| +2% | +$4.97K | 0.05% | 87 |
|
|
2022
Q2 | $312K | Sell |
2,034
-66
| -3% | -$10.1K | 0.05% | 88 |
|
|
2022
Q1 | $340K | Sell |
2,100
-14
| -0.7% | -$2.27K | 0.05% | 91 |
|
|
2021
Q4 | $286K | Buy |
2,114
+8
| +0.4% | +$1.08K | 0.04% | 94 |
|
|
2021
Q3 | $227K | Buy |
2,106
+42
| +2% | +$4.53K | 0.04% | 106 |
|
|
2021
Q2 | $233K | Hold |
2,064
| – | – | 0.04% | 101 |
|
|
2021
Q1 | $223K | Sell |
2,064
-49
| -2% | -$5.29K | 0.04% | 100 |
|
|
2020
Q4 | $226K | Sell |
2,113
-173
| -8% | -$18.5K | 0.05% | 98 |
|
|
2020
Q3 | $200K | Buy |
2,286
+140
| +7% | +$12.2K | 0.05% | 96 |
|
|
2020
Q2 | $211K | Buy |
+2,146
| New | +$211K | 0.06% | 91 |
|